Natera, Inc. (NTRA) - Long-Term Liabilities to Capital

To drive expansion, Natera, Inc. (NTRA) is actively recruiting leading bioinformaticians and geneticists while retaining key product creators. Management is betting on expansion within the genetic diagnostics sector, allocating capital toward research to achieve exponential sales growth. This price chart on GURU.Markets illustrates the trend with the metric at 0.07, aiding the analysis of the reproductive health business. However, international conflicts are creating challenges regarding supply chains and patent protection.

This ratio determines the share of long-term liabilities within the equity structure, allowing for an assessment of financing stability and the company's degree of financial leverage. By analyzing the history of long-term debt-to-equity, an investor can evaluate the bankruptcy risk of Natera, Inc. amid intensive development costs for genetic tests and a dependence on government payments.